Stockreport

Intellia (NTLA) Banks on Genome Editing Pipeline Amid Rivalry [Yahoo! Finance]

Intellia Therapeutics, Inc.  (NTLA) 
Last intellia therapeutics, inc. earnings: 2/27 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.intelliatx.com/investor-overview
PDF The company is collaborating with Regeneron Pharmaceuticals REGN for the development of NTLA-2001. NTLA-2001 is being studied for two indications: ATTR amyloidosis wit [Read more]